Dispelling Misconceptions in Biopharmaceutical IP Regulation

On World IP Day, Kirsten Axelsen, Senior Advisor of the Incubate Policy Lab, joins host John Stanford to announce the newest whitepaper, delve into the myths and realities surrounding IP in the pharmaceutical industry, explore the dynamics of patent regulations, and touch on the contentious discussions around patent thickets and pharmaceutical pricing under new legislative environments like the Inflation Reduction Act.Join us as we also discuss:What to expect out of the Incubate Policy LabThe role that venture investment plays in advancing promising science and technology.The latest whitepaper that addresses misconceptions about IPThe implications of IRA policies in weakening the generics industry, potentially disrupting the balance that has historically led to affordable drug pricing post-patent expiration.